← Back to Screener
Q/C Technologies, Inc. Common Stock (QCLS)
Price$4.20
Value ScoreD
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)17.30%
Price vs S&P 500 (4W)12.19%
VGM Score43.52
Market Capitalization$34.32M
All Metrics
Book Value / Share (Quarterly)$3.02
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-1.24
Price vs S&P 500 (YTD)-1.41%
Gross Margin (TTM)24.73%
Net Profit Margin (TTM)-501.52%
EPS (TTM)$-35.49
10-Day Avg Trading Volume0.60M
EPS Excl Extra (TTM)$-35.49
EPS (Annual)$-6.72
Dividend / Share (Annual)$0.50
ROI (Annual)-158.69%
Gross Margin (Annual)7.64%
Net Profit Margin (5Y Avg)-298.68%
Cash / Share (Quarterly)$1.65
ROA (Last FY)-109.05%
EBITD / Share (TTM)$-6.58
ROE (5Y Avg)-94.13%
Operating Margin (TTM)-500.57%
Cash Flow / Share (Annual)$-2.67
P/B Ratio1.45x
P/B Ratio (Quarterly)0.61x
Net Income / Employee (Annual)$-5,813,600
Net Interest Coverage (TTM)-40.56x
ROA (TTM)-40.68%
EPS Incl Extra (Annual)$-6.72
Current Ratio (Annual)1.40x
Quick Ratio (Quarterly)3.52x
3-Month Avg Trading Volume0.92M
52-Week Price Return-73.61%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.22
P/S Ratio (Annual)20.60x
Asset Turnover (Annual)0.21x
52-Week High$33.56
Operating Margin (5Y Avg)-298.11%
EPS Excl Extra (Annual)$-6.72
26-Week Price Return33.23%
Quick Ratio (Annual)1.27x
13-Week Price Return12.63%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)3.71x
Enterprise Value$33.19M
Asset Turnover (TTM)0.21x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)0.00x
Pretax Margin (Annual)-651.36%
Cash / Share (Annual)$2.53
3-Month Return Std Dev111.28%
Gross Margin (5Y Avg)45.57%
Net Income / Employee (TTM)$-5,813,600
ROE (Last FY)-158.69%
Net Interest Coverage (Annual)-4.11x
EPS Basic Excl Extra (Annual)$-6.72
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-35.49
Receivables Turnover (Annual)0.00x
ROI (TTM)-65.06%
P/S Ratio (TTM)41.03x
Pretax Margin (5Y Avg)-301.23%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-101.82%
Year-to-Date Return9.52%
5-Day Price Return4.55%
EPS Normalized (Annual)$-6.72
ROA (5Y Avg)-77.25%
Net Profit Margin (Annual)-651.36%
Month-to-Date Return16.53%
EBITD / Share (Annual)$-6.56
Operating Margin (Annual)-650.86%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-94.13%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-35.49
P/TBV (Quarterly)1.50x
P/B Ratio (Annual)0.27x
Dividend / Share (TTM)$0.03
Inventory Turnover (TTM)0.00x
Pretax Margin (TTM)-501.52%
Book Value / Share (Annual)$4.38
Price vs S&P 500 (13W)2.88%
Dividend Yield (TTM)0.39%
Beta2.16x
Revenue / Share (TTM)$0.00
ROE (TTM)-65.06%
52-Week Low$2.50
vGradeD
mGradeC
vgmGradeC
Show chart for
Industry Peers — In Vitro Diagnostics(18)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
QCLSQ/C Technologies, Inc. Common Stock | D | — | C | $4.20 |
| IDXXIdexx Laboratories Inc | D | B | C | $566.79 |
| LNTHLantheus Holdings, Inc | C | B | B | $97.13 |
| NNNNAnbio Biotechnology Class A Ordinary Shares | F | B | A | $30.17 |
| CLDXCelldex Therapeutics, Inc | F | F | B | $30.14 |
| NTLAIntellia Therapeutics, Inc | D | C | B | $13.73 |
| NEOGNeogen Corp | C | C | C | $8.92 |
| QDELQuidelOrtho Corporation Common Stock | B | C | D | $13.27 |
| ACHVAchieve Life Sciences, Inc. | F | F | B | $5.30 |
| MYGNMyriad Genetics Inc | C | C | D | $4.28 |
| TKNOAlpha Teknova, Inc. Common Stock | C | C | B | $5.37 |
About
Q/C Technologies Inc develops blockchain infrastructure using photonic computing technology to improve processing speed and energy efficiency. The company's laser-based processor architecture is designed to address computational limitations in blockchain networks while reducing power consumption. By integrating photonic computing with cryptocurrency systems, Q/C Technologies targets next-generation distributed ledger applications requiring high performance and sustainability.